About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 4

Effect of Dexmedetomidine and Total Intravenous Anesthesia on Endothelial Damage-Related Biomarkers

NCT06897696•Firat University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Endothelial DamageDexmedetomidineSyndecan 1+1 more

Interventions

Dexmedetomidine+propofol+remifentanyl group

propofol+remifentanyl group

Locations

1

Turkey (Türkiye)

Locations (1)

Firat University Hospital

Elâzığ, Turkey (Türkiye)

Key Dates

Start Date

April 10, 2025

Primary Completion Date

October 31, 2025

Completion Date

October 31, 2025

Last Updated

January 6, 2026

Related Studies

RECRUITINGPhase 4

Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia

NCT06853431

Preoperative AnxietyPreoperative Sedation+6 more

Intraoperative Infusion of Either Lidocaine or Dexmedetomidine on Regional Cerebral Oxygen Saturation and Postoperative Delirium in Elderly Patients Undergoing Abdominal Surgeries

NCT07108764

Intraoperative InfusionLidocaine+5 more

RECRUITINGPhase 4

Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery

NCT06062550

Scoliosis CorrectionEsketamine+3 more

RECRUITINGPhase 4

Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality

NCT05950646

Old AgeKnee Replacement Surgery+4 more

Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty

NCT06837844

Intrathecal DexmedetomidineAdductor Canal Block+2 more

RECRUITINGPhase 3

Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity

NCT06067958

Retinopathy of PrematurityDexmedetomidine

View all related studies

Sponsors

Lead Sponsor

Firat University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 6, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions